Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625963 · ClinicalTrials.gov registry record
The Study Of CT Scans and Echo Parameters in Patients With PAH
A clinical trial of Pulmonary Hypertension, sponsored by Northwell Health.
- Completed
- Registry status
- 71
- Enrollment target
- 1
- Study location
NCT00625963: Completed study of Pulmonary Hypertension, sponsored by Northwell Health.
NCT00625963 is a study of Pulmonary Hypertension that has completed, run by Northwell Health. The registered enrollment target is 71 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00625963, a study of Pulmonary Hypertension, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.
Primary Outcome
Correlation of Pulmonary artery diameter as measured by CT scan and Pulmonary artery systolic pressure as measured by Echocardiogram.
Conditions Studied
Study Locations (1)
New York
- North Shore-Long Island Jewish Health System - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-07 |
What the finished NCT00625963 record still lists
NCT00625963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT00625963 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00625963 about?
NCT00625963 is a clinical study titled "The Study Of CT Scans and Echo Parameters in Patients With PAH". Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patte...
What is the current status of trial NCT00625963?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2007-04. Estimated completion is 2011-07.
What conditions does trial NCT00625963 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
Who is sponsoring clinical trial NCT00625963?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00625963 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00625963's enrollment target sits among peer trials
71 36th of 72 higher than 37 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia